Patents
Patents for C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
08/2008
08/27/2008EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases
08/06/2008CN101238132A Spirochromanone derivatives as acetyl coenzyme A carboxylase(ACC) inhibitors
08/05/2008CA2331593C Metabolites of ecteinascidin 743
07/2008
07/30/2008EP1950212A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase
07/29/2008US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
07/24/2008US20080176763 Collection of Traceable Compounds and Uses Thereof
07/16/2008EP1944301A1 Novel benzoxathiin derivative
05/2008
05/15/2008US20080113994 For example, 6-chloro-9-methyl-9-(3,4,5-trimethoxyphenyl)-4,9-dihydro-3H-furo[3,4-b]quinolin-1-one; for controlling animal pests, in particular insects, arachnids and mites, which are found in enclosed spaces such as dwellings
05/06/2008CA2327468C Semi-synthetic ecteinascidins
05/01/2008US20080103230 Monomers for polyepisulfides, polythiourethanes, or acrylic esters with internal thio groups; optical lens protective coatings with a high refractive index; reacting a bis-ethylenetrithiocarbonate sulfide or bis-ethylenetrithiocarbonate with an oxirane or thiirane and tetrafluoroboric acid catalyst
04/2008
04/29/2008US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
04/17/2008US20080090817 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
04/16/2008EP1910375A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
03/2008
03/27/2008WO2008036272A1 HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF
03/27/2008CA2663528A1 Heterocyclic inhibitors of c-met and uses thereof
03/26/2008CN100376569C Inhibitors of farnesyl protein transferase
02/2008
02/28/2008WO2008009700A8 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
02/28/2008WO2008007123A3 Pharmaceutical compounds
02/20/2008EP1888594A2 Gabaergic agents to treat memory deficits
01/2008
01/24/2008WO2008011406A2 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
01/24/2008WO2008009700A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
01/24/2008US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders
01/24/2008US20080020989 Cancer, hepatitis C virus infection, mmunomodulators; Acetic acid 2-acetoxymethyl-5-(5-formylamino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-isopropoxycarbonyloxy-tetrahydro-furan-3-yl ester
01/24/2008CA2658261A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
01/17/2008WO2008007123A2 Pharmaceutical compounds
01/10/2008US20080009542 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide
01/09/2008EP1876180A2 Semi-synthetic ecteinascidins
01/09/2008EP1874117A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
12/2007
12/25/2007US7312213 Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds
12/13/2007US20070287701 6-({[(1-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
12/12/2007EP1863774A2 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/06/2007WO2007139569A1 Novel lapachone compounds and methods of use thereof
12/06/2007US20070282103 Process for the Preparation of Thiazolopyrimidines
12/06/2007CA2653472A1 Novel lapachone compounds and methods of use thereof
11/2007
11/28/2007CN101080394A Heterocyclical chromophore architectures
11/07/2007EP1852434A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
11/07/2007CN101068795A Heterocyclical chromophore architectures with novel electronic acceptor systems
11/01/2007WO2007122258A1 Tryclic nitrogen containing compounds and their use as antibacterials
10/2007
10/31/2007CN101065016A Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/24/2007EP1846416A2 Antibacterial agents
10/18/2007US20070244096 Fused Bicyclic Nitrogen-Containing Heterocycles
10/10/2007EP1756119B1 Collection of traceable compounds and uses thereof
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/03/2007CN101048390A Heterocyclical chromophore architectures
09/2007
09/26/2007EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues
09/26/2007CN100339375C Metabolites of ecteinascidin 743
09/19/2007CN100338071C New benzo-oxazino-isoindole derivatives, useful for treating cancers, are inhibitors of the cell cycle
09/05/2007CN101029046A Substituted isoandrographolide derivative, its production and medicinal composition
08/2007
08/29/2007EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia
08/29/2007CN100334086C Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives
08/21/2007CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides
08/15/2007EP1067933B1 Semi-synthetic ecteinascidins
08/08/2007CN101012234A Non-periphery substituted phthalocyanine metal complex and preparing method thereof
08/02/2007WO2007087276A1 Aurora kinase modulators and method of use
07/2007
07/19/2007US20070166871 liquid crystal displays; films; solar cells
07/11/2007EP1805150A2 Heterocyclical chromophore architectures
07/11/2007EP1805144A1 Heterocyclical chromophore architectures
07/05/2007US20070155971 Chiral diphosphorus compounds and their transition metal complexes
07/05/2007US20070155730 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase
06/2007
06/28/2007WO2007071936A1 Heterocyclic compounds, their preparation and their use as antibacterials
06/28/2007WO2007070984A1 Spiroketals
06/28/2007CA2634468A1 Spiroketals
06/20/2007EP1797101A1 An improved process for the preparation of levofloxacin hemihydrate
06/20/2007EP1796467A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
06/13/2007EP1794137A2 Specific kinase inhibitors
06/13/2007EP1142575B1 Dry skin remedies
05/2007
05/31/2007US20070123475 podophyllotoxin analogs such as 4-beta-[(4''-benzamido)-amino]-4'-demethyl-epipodophyllotoxins and their 4'-ester derivatives used in the chemotherapy for various types of cancer
05/24/2007US20070117973 Chalcogen-containing fused polycyclic organic material and method for producing same
05/16/2007EP1784410A2 Antibacterial agents
05/16/2007CN1964977A Annelated quinoline derivatives as pesticide
05/16/2007CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/09/2007EP1781669A2 Antibacterial agents
05/03/2007WO2007049798A1 Novel benzoxathiin derivative
05/03/2007CA2627139A1 Novel benzoxathiin derivative
04/2007
04/25/2007EP1305294B1 Imidazolyl derivatives
04/12/2007WO2007040166A1 Novel fused pyrrole derivative
04/12/2007CA2623154A1 Novel fused pyrrole derivative
04/05/2007WO2006117800B1 Novel 3, 4-propylenedioxythiophene derivatives with pendant functional groups
04/04/2007EP1556387B1 Substituted benzol e| 1,4| oxazino 3,2-g| isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
04/04/2007CN1308316C Alpha-phenyl-beta-ketosulfone
04/03/2007US7199125 Spiro-cyclic compounds useful as anti-inflammatory agents
03/2007
03/27/2007CA2179733C Anticonvulsant pseudofructopyranose sulfamates
03/21/2007CN1305860C Condensed quinazoline derirative used as tyrosine kinase inhibitor
03/20/2007US7193092 Chiral diphosphorus compounds and their transition metal complexes
03/07/2007CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof
03/06/2007US7186832 anticancer agents; antidiabetic agents; autoimmune disease; restenosis; antiarthritic agents; skin disorders; cardiovascular disorders; antiinflammatory agents
02/2007
02/28/2007EP1756119A1 Collection of traceable compounds and uses thereof
02/22/2007WO2006117800A3 Novel 3, 4-propylenedioxythiophene derivatives with pendant functional groups
02/15/2007WO2007018660A2 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits
02/15/2007CA2607226A1 Gabaergic agents to treat memory deficits
02/14/2007CN1914213A Process for the preparation of thiazolopyrimidines
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
02/13/2007US7176236 Water-soluble etoposide analogs and methods of use thereof
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
01/2007
01/25/2007WO2007011809A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
01/25/2007CA2614963A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
01/17/2007CN1896064A Metabolites of ecteinascidin 743
01/09/2007US7160485 Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives, related anisotropic films, and methods for making
01/04/2007US20070004707 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride; schizophrenia, Parkinson's disease, psychosis associated with Lewy body disease, dementia, memory deficit; psychosis
1 2 3 4 5 6 7 8 9 10 11